115379 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39026)
  2. GSK Faculty (22463)
  3. Solid Tumor Oncology Division (22051)
  4. Surgery (21243)
  5. Sloan Kettering Institute Faculty (16084)
  6. Survivorship Research (15761)
  7. Center for Hematologic Malignancies (13261)
  8. Hematologic Malignancies, Division of (13086)
  9. Sloan Kettering Institute Postdocs (12932)
  10. Department of Pathology and Laboratory Medicine (12602)
Formats
  1. Journal Article (66748)
  2. Meeting Abstract (33628)
  3. Book Section (5027)
  4. Review (3743)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39026)
  2. GSK Faculty (22463)
  3. Solid Tumor Oncology Division (22051)
  4. Surgery (21243)
  5. Sloan Kettering Institute Faculty (16084)
  6. Survivorship Research (15761)

More Groups

People
  1. Marc Ladanyi (1326)
  2. Robert Motzer (1243)
  3. Victor Reuter (1224)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1049)

More People

Years
  1. 2025 (1983)
  2. 2024 (5385)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115379)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Updated results from the trastuzumab deruxtecan (T-DXd) 5.4 mg/kg triplet combination of DESTINY-Gastric03 (DG-03): First-line (1L) T-DXd with fluoropyrimidine (FP) and pembrolizumab in advanced/metastatic HER2-positive (HER2+) esophageal adenocarcinoma, gastric cancer (GC), or gastroesophageal junction adenocarcinoma (GEJA)
    Meeting Abstract

    Janjigian, Y. Y.; Van Laarhoven, H. W. M.; Rha, S. Y.; Kozlov, V.; Oh, D. Y.; Gravina, A.; Rapatoni, L.; Shoji, H.; Hofheinz, R. D.; Chen, L. T.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • The prognostic value of HER2 gene dosage and heterogeneity at a single-cell resolution in gastroesophageal adenocarcinoma
    Meeting Abstract

    Parashar, Y.; Culnane, L.; Remland, J.; Nambiar, C.; Yuan, C.; Nasta, S.; Bard, A.; Park, H.; Klempner, S. J.; Giannakis, M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Concordance between human epidermal growth factor receptor 2 (HER2) status by immunohistochemistry (IHC) and next-generation sequencing (NGS) in tissue and blood samples from gastric and gastroesophageal junction cancers (GC/GEJC)
    Meeting Abstract

    Maron, S. B.; Burke, K.; Gupta, P.; Sarlo, K.; Tesic-Schnell, M.; Woo, M. S. A.; Klempner, S. J.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Zanidatamab dose optimization in patients with HER2-positive biliary tract cancer (BTC)
    Meeting Abstract

    Trueman, S.; Wu, L.; Girgis, S.; Vaidya, K.; Meric-Bernstam, F.; Harding, J. J.; Pant, S.; Zhao, Y.; Garfin, P. M.; Iannone, R.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Association between adjuvant component of perioperative chemotherapy and survival outcomes in resected gastric cancer (GC)
    Meeting Abstract

    Sreeram, A.; Yeh, C.; Toumbacaris, N.; Capanu, M.; Shimada, S.; Gu, P.; Janjigian, Y. Y.; Ilson, D. H.; Strong, V. E.; Ku, G. Y.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Influence of preoperative Lynch syndrome diagnosis on surgery in patients with colorectal cancer
    Meeting Abstract

    Abbass, M. A.; Nielsen Young, S. M.; Russell, E. M.; Esplin, E.; Pineda-Alvarez, D.; Heald, B.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Adagrasib (Ada) + cetuximab (Cetux) for KRAS(G12C)-mutated metastatic colorectal cancer (mCRC): Longer follow-up analysis from KRYSTAL-1
    Meeting Abstract

    Yaeger, R.; Uboha, N. V.; Klempner, S. J.; Bekaii-Saab, T. S.; Sabari, J. K.; Barve, M. A.; Saltzman, J. N.; Peguero, J. A.; Paulson, A. S.; Jänne, P. A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Risk of residual tumor following removal of a malignant colorectal polyp with high-risk features
    Meeting Abstract

    Tawantanakorn, T.; Bektas, A. B.; Hill, M.; Widmar, M.; Karagkounis, G.; Wei, I. H.; Smith, J. J.; Pappou, E.; Nash, G. M.; Paty, P.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • NRG-GI007: Secondary endpoints of safety assessment and clinical complete response (cCR) of chemoradiation with endoscopically injected oncolytic virus OBP-301 in medically inoperable esophageal cancer
    Meeting Abstract

    Ku, G. Y.; Moughan, J.; Williams, T. M.; Adusumilli, P. S.; Nishimura, M.; Yock, A.; Mehta, R.; Frakes, J. M.; Wu, A. J. C.; Miller, E. D.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Nivolumab (NIVO) + chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): 5-year (y) follow-up results from CheckMate 649
    Meeting Abstract

    Janjigian, Y. Y.; Moehler, M. H.; Ajani, J. A.; Shen, L.; Garrido, M.; Gallardo, C.; Wyrwicz, L.; Yamaguchi, K.; Cleary, J. M.; Elimova, E.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save